OSTX
OS Therapies IncCompany Information
- Company Name
- OS Therapies Inc
- CIK
- CIK0001795091
- Category
- <br>Emerging growth company
- Ticker: Exchange
- OSTX: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- OSTX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2025-05-07
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 208,720
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,859,434
- Shares outstanding
- 45,283,071
- Ownership
- 6.31%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- 16.05%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Notes A Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 1 | ||||||
Assets | ||||||||||||||||
| Related Party | - | - | - | - | - | 0 | - | - | - | - | ||||||
Assets Current | ||||||||||||||||
| Convertible Notes A Related Party Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Convertible Notes B Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 5 | ||||||
| Convertible Notes C Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 4 | ||||||
| Cash And Cash Equivalents At Carrying Value | - | 1 | - | 2 | - | 3 | - | 2 | - | - | ||||||
| Cash | 0 | 1 | 0 | - | 3 | 3 | 6 | 2 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | - | - | 0 | 0 | 1 | 1 | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | - | - | - | - | - | - | 0 | - | - | ||||||
| Other Receivables | - | - | - | - | - | - | - | 0 | 0 | - | ||||||
| Assets Current | 4 | 1 | 0 | 2 | 4 | 4 | 6 | 2 | 1 | 1 | ||||||
Assets Noncurrent | ||||||||||||||||
| Convertible Notes D Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 2 | ||||||
| Convertible Notes E Net Debt Discount | - | - | - | - | - | - | - | - | 0 | 1 | ||||||
| Convertible Notes F Net Debt Discount | - | - | - | - | - | - | - | - | 1 | 2 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets | ||||||||||||||||
| Deferred Offering Costs | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Deposits Assets Noncurrent | 6 | 6 | 7 | 7 | 7 | 0 | - | - | - | - | ||||||
| Assets Noncurrent | 6 | 6 | 7 | - | - | - | 0 | - | - | - | ||||||
| Assets | 10 | 7 | 7 | 9 | 10 | 4 | 6 | 2 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||
| Deferred Costs Current | - | - | - | - | - | - | - | - | 1 | - | ||||||
| Accounts Payable Current | - | - | 10 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | ||||||
| Accrued Liabilities Current | - | - | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current | 20 | 15 | - | - | - | - | - | - | - | - | ||||||
| Accrued Payroll Taxes Current | 0 | 0 | 0 | 0 | - | 0 | - | 0 | 0 | 0 | ||||||
| Dividends Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable Current | - | 1 | - | - | - | - | - | - | - | 2 | ||||||
| Liabilities Current | 21 | 17 | 12 | 4 | 3 | 4 | 5 | 3 | 28 | 26 | ||||||
Liabilities Noncurrent | ||||||||||||||||
| Warrants And Rights Outstanding | - | - | - | - | - | 1 | 2 | - | - | - | ||||||
| Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 21 | 17 | 12 | 4 | 4 | 4 | 5 | 3 | 28 | 27 | ||||||
Temporary Equity | ||||||||||||||||
| Short Term Borrowings | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Temporary Equity Value Excluding Additional Paid In Capital | 1 | 1 | 1 | 1 | 2 | 5 | 4 | - | - | - | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | 1 | 1 | 1 | 1 | 2 | 5 | 4 | - | - | - | ||||||
Stockholders Equity | ||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 74 | 67 | 61 | 57 | 52 | 38 | 35 | 35 | 5 | 5 | ||||||
| Retained Earnings Accumulated Deficit | -86 | -78 | -67 | -54 | -47 | -42 | -38 | -35 | -33 | -31 | ||||||
| Stockholders Equity | -12 | -11 | -6 | 4 | 5 | -4 | -3 | -1 | -27 | -26 | ||||||
| Liabilities And Stockholders Equity | 10 | 7 | 7 | 9 | 10 | 4 | 6 | 2 | 1 | 1 | ||||||
| Series A Preferred Stock | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Authorized | 3 | 3 | - | - | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Issued | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 50 | 50 | 50 | 150 | 50 | 50 | 50 | ||||||
| Common Stock Shares Issued | 45 | 39 | 37 | 33 | 30 | 21 | 21 | 21 | 6 | 12 | ||||||
| Shares Outstanding | 45 | 39 | 37 | 33 | 30 | 21 | 21 | 21 | 6 | 12 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialOS Therapies Inc (OSTX) — SEC Financial Statements & Analysis
OS Therapies Inc (OSTX) is a pharmaceutical preparations company, incorporated in DE. OS Therapies Inc trades on NYSE as: OSTX. OS Therapies Inc (OSTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, OS Therapies Inc carries a market cap of $86.04M, a P/E ratio of -2.19x, a P/B ratio of -7.22x, an enterprise value of $85.83M, and an EV/EBITDA multiple of -2.31x. On profitability, it posts a Return on Equity (ROE) of 1129.53% and a Return on Assets (ROA) of -389.65%. Per share, it reports EPS of $-0.87, diluted EPS of $-0.90, free cash flow per share of $-0.41, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 176.30% year-over-year and EPS growth of 81.01% year-over-year. On the balance sheet, it maintains a current ratio of 0.18x, a quick ratio of 0.16x, working capital of $-17.00M, a debt-to-equity ratio of -1.74x, a debt ratio of 2.1, an interest coverage ratio of -464.76x, free cash flow of $-18.53M (TTM), and net debt of $-205.03K. Figures sourced from SEC EDGAR.
- Market Cap
- $86.04M
- P/E TTM
- -2.19x
- EPS TTM
- $-0.87
- P/B TTM
- -7.22x
- ROE TTM
- 1129.53%
- ROA TTM
- -389.65%
- Debt To Equity
- -1.74x
- Free Cash Flow TTM
- $-18.53M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is OS Therapies Inc in?
OS Therapies Inc (OSTX) operates in the Pharmaceutical Preparations industry.
What exchange does OSTX trade on?
OS Therapies Inc (OSTX) trades on the NYSE.
Where is OS Therapies Inc incorporated?
OS Therapies Inc is incorporated in DE.
When was OS Therapies Inc (OSTX)'s most recent SEC filing?
OS Therapies Inc (OSTX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is OSTX's market cap?
OS Therapies Inc (OSTX) has a market capitalization of $86.04M as of 2026-06-30.
What is OSTX's EPS (earnings per share)?
OS Therapies Inc (OSTX)'s trailing twelve month EPS is $-0.87 as of 2026-06-30.
What is OSTX's ROE (return on equity)?
OS Therapies Inc (OSTX)'s trailing twelve month Return on Equity (ROE) is 1129.53% as of 2026-06-30.
What is OSTX's ROA (return on assets)?
OS Therapies Inc (OSTX)'s trailing twelve month Return on Assets (ROA) is -389.65% as of 2026-06-30.
What is OSTX's EV/EBITDA?
OS Therapies Inc (OSTX)'s trailing twelve month EV/EBITDA is -2.31x as of 2026-06-30.